Australia at the heart of ‘transformational’ melanoma cancer vaccine breakthrough
A world-first cancer vaccine has been shown to radically reduce the risk of melanoma recurrence and death. The results from an Australian-led phase 3 human trial revealed a 42 per cent reduction in the risk of melanoma recurrence. Melanoma Institute Australia medical director and principal investigator Georgina Long said the results were better than she










